A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease
A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease
Not yet recruiting · NCT07789873 · Registry updated 2026-08-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A 28-Day Study of GAL-101 in Participants With Mild to Moderate Alzheimer's Disease | Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Plaque, Amyloid | Not yet recruiting | Phase 2 | 2026-08-27 | NCT07789873 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Galimedix Therapeutics Inc | 2 |
0 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| No products are listed yet. | |||